What is Alectinib?

Category: Prescription Drugs

Most popular types: Alecensa

false

Alectinib is a generic drug commonly used to treat non-small cell lung cancer. This treatment blocks anaplastic lymphoma kinase activity.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 2
Mild 0
None 0

Commonly reported side effects and conditions associated with Alectinib

Side effect Patients
Fatigue 2
Edema (fluid retention) 1
Leg pain with exertion 1

Dosages

Based on patients currently taking Alectinib

Dosage Patients
600 mg twice daily 3

Duration

Currently taking Alectinib

Duration Patients
1 - 2 years 3
Adherence
Adherence Evaluations
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0

What people switch to and from

Patients started taking Alectinib after stopping:

Treatment Patients
Crizotinib (Xalkori) 2
Ceritinib (Zykadia) 1
Last updated:
There are no evaluations for Alectinib.